Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Annovation Biopharma Inc.

Division of The Medicines Co.
www.annovation.eriksengraphics.com

Latest From Annovation Biopharma Inc.

“Build-To-Buy” Startup Model Alive And Kicking, Invested Execs Say

VCs and big pharma execs, speaking at CALBIO, said that even in today’s freer economic climate, investing early in startups, with an option to buy when the time is right, is still a viable business strategy.

Strategy Deals

Deals Shaping The Medical Industry, March 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February 2015.

BioPharmaceutical Medical Device

Deal Watch: Valeant’s Financial/Commercial Strength Offers A New Chance For Provenge

AstraZeneca buys out respiratory franchise from Actavis, which it had gained a year prior with its purchase of Forest. Mylan announced two deals Feb. 2, collaborating in COPD with Theravance and buying women’s health products from India’s Famy Care.

BioPharmaceutical Deals

Atlas-Backed Firm Will Seek Pan-Ataxia Therapy With Biogen’s Assistance

Biogen participates with Atlas Venture in a $17 million Series A financing for Ataxion, which will seek to advance preclinical ion channel modulators for hereditary ataxias.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • The Medicines Co.
  • Senior Management
  • David S Grayzel, PhD, Pres. & CEO
    Scott Chappel, PhD, CSO
  • Contact Info
  • Annovation Biopharma Inc.
    Phone: (617) 588-2644
    25 First St.
    Ste. 303
    Cambridge, MA 02141
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register